A detailed history of Act Two Investors LLC transactions in Amgen Inc stock. As of the latest transaction made, Act Two Investors LLC holds 46,220 shares of AMGN stock, worth $13.6 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares
46,220
Holding current value
$13.6 Million
% of portfolio
2.69%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$262.28 - $309.85 $12.1 Million - $14.3 Million
46,220 New
46,220 $12.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Act Two Investors LLC Portfolio

Follow Act Two Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Two Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Two Investors LLC with notifications on news.